Skip to main content

Table 3 Average chemiluminescent signal intensities

From: Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products

AnalytePBMCsec (mean gray values)Placebo (mean gray values)
Apolipoprotein A-I163 ± 2411 ± 0
BAFF161 ± 2212 ± 0
CD14134 ± 3619 ± 2
Chitinase 3-like 1220 ± 209 ± 0
EGF95 ± 2012 ± 1
emmprin124 ± 3728 ± 1
ENA-78112 ± 609 ± 1
Endoglin166 ± 2751 ± 0
IFN-γ84 ± 966 ± 3
IL-8192 ± 288 ± 0
Kallikrein 395 ± 4079 ± 4
Lipocalin-2162 ± 114 ± 0
MIF149 ± 117 ± 0
MMP-9150 ± 223 ± 0
Myeloperoxidase153 ± 1091 ± 0
Osteopontin105 ± 2269 ± 5
PDGF-AA174 ± 2913 ± 2
pentraxin 3174 ± 9165 ± 2
PF4133 ± 294 ± 0
RANTES149 ± 2716 ± 0
RBP4132 ± 55115 ± 2
Resistin113 ± 6027 ± 0
PAI-1255 ± 012 ± 0
Thrombospondin-1119 ± 143 ± 0
uPAR147 ± 609 ± 1
Vitamin D BP138 ± 2568 ± 5
CD31130 ± 55 ± 0
  1. Cytokines selected for subsequent ELISA-assisted quantifications are highlighted in italics
  2. BAFF B cell activating factor, CD14 cluster of differentiation 14, EGF epidermal growth factor, ENA-78 epithelial-derived neutrophil-activating protein 78, IFN-γ interferon gamma, IL-8 interleukin-8, MIF macrophage migration inhibitory factor, MMP9 matrix metallopeptidase 9, PDGF-AA platelet-derived growth factor subunit A, PF4 platelet factor 4, RANTES regulated and normal T cell expressed and secreted, RBP retinol binding protein, PAI-1 plasminogen activator inhibitor-1, uPAR urokinase-type plasminogen activator receptor, vitamin D-BP vitamin D-binding protein, CD31 cluster of differentiation 31